{"id":"W2999203985","doi":"10.1016/s2213-2600(19)30267-x","title":"Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study","year":2020,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Medical Research Council; Novartis Institutes for BioMedical Research; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Oncology; Open label; Internal medicine; Lung; Phases of clinical research; Small Cell Lung Carcinoma; Carcinoma; Mutant; Small-cell carcinoma; Clinical trial; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013982,0.001288152,0.002139916,0.000252312,0.0003050961,0.001055759,0.0005943063,0.001401922,0.001554535],"category_scores_gemma":[0.001288684,0.0005426022,0.001848505,0.0002924133,0.0007921514,0.001182274,0.00025952,0.00232871,0.0005078493],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009160409,"about_ca_system_score_gemma":0.0008617686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007571371,"about_ca_topic_score_gemma":0.001946819,"domain_scores_codex":[0.9994691,0.0002374491,0.00003864531,0.0001031043,0.00006513649,0.00008656235],"domain_scores_gemma":[0.9993499,0.0001486464,0.0002168592,0.00005352818,0.00005387151,0.0001772671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8930131,0.008407892,0.009289449,0.001075304,0.002852978,0.0001622608,0.0001592697,0.001318975,0.01609142,0.0001421382,0.001809083,0.06567811],"study_design_scores_gemma":[0.6688197,0.2760977,0.0449616,0.00009935878,0.002491812,0.0004682803,0.0001110729,0.001597138,0.002284575,0.0002824983,0.002701052,0.00008521193],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932976,0.004488508,0.0002272614,0.0002873478,0.00007785922,0.0003428589,0.0005216367,0.00003618625,0.0007206142],"genre_scores_gemma":[0.9944884,0.002207146,0.0004835013,0.0005470859,0.0001013071,0.0003344059,0.0009608371,0.0000130278,0.0008641907],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002139916,"threshold_uncertainty_score":0.007394493,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05330810440844667,"score_gpt":0.3645879452239147,"score_spread":0.311279840815468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}